Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK
Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals...
US FDA approves Janssen’s PONVORY for relapsing multiple sclerosis
The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s (JNJ) PONVORY...
Gilead and Novo Nordisk Expand NASH Clinical Collaboration
Gilead Sciences, Inc. and Novo Nordisk A/S announced that the companies have expanded their clinical...
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene...
Insilicos Chemistry42 AI system integrated into UCBs drug discovery programs
Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico's Chemistry42™ into...
PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP Manufacturing...
PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the...
Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a supply...
AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan,...
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced plans for...
CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on...
Clinerion and Medexprim join forces to combine clinical and imaging data for research
Clinerion and Medexprim have concluded a three-year partnership dedicated to the merger of electronic health...
